Re-runs extraction for each period with period-end year from max(2023, current year − 2) through the current year, oldest first (up to three reporting years). This can take a long time.
Sector: Healthcare
RU_OZPH
Net debt (table and EV/EBITDA): |short-term borrowings| + |long-term borrowings| + |other financial liabilities| when extracted + |non-controlling interest| when extracted − |cash and equivalents|; amounts in millions of the reporting currency.
Shares: connector/market_inputs
| Period | Issues |
|---|---|
| 2023-06-30 Q2 | ✓OK |
| 2023-09-30 9M | ✓OK |
| 2023-09-30 Q3 | ⚠Warn 1 |
| 2023-12-31 FY | ✓OK |
| 2023-12-31 Q4 | ✗Errors 1 |
| 2024-03-31 Q1 | ✗Errors 1Warn 2 |
| 2024-06-30 Q2 | ⚠Warn 1 |
| 2024-09-30 9M | ⚠Warn 2 |
| 2024-09-30 Q3 | ✗Errors 1Warn 2 |
| 2024-12-31 FY | ✓OK |
| 2024-12-31 Q4 | ⚠Warn 1 |
| 2025-03-31 Q1 | ✓OK |
| 2025-06-30 Q2 | ✗Errors 1Warn 2 |
| 2025-09-30 9M | ✓OK |
| 2025-09-30 Q3 | ✓OK |
| 2025-12-31 FY | ✓OK |
| 2025-12-31 Q4 | ⚠Warn 2 |
Monetary columns are in M USD, one decimal; scale (K/M/B/T) keeps values readable. For the period (default) shows P&L and cash flow for that row’s reporting window: quarterly amounts when the feed uses quarter-duration facts (typical US 10-Q revenue and income), quarterly cash flows after stripping YTD where only cumulative tags exist, and an implied Q4 on 31 Dec FY rows (P&L: FY minus Q1–Q3; operating / investing cash flow: FY 12m minus 9M YTD to 30 Sep when sourced from SEC builder evidence) so they match 10-Q scale. Some issuers still use cumulative YTD minus the prior row in the same calendar year. As reported shows values stored on each row (e.g. full-year on FY). Balance sheet is always as reported. Source JSON may use millions etc.; conversion uses amounts_unit per row.
| Date | Period | Status | RevenueM USD | Operating profitM USD | D&AM USD | EBITDAM USD | Net profitM USD | Operating CFM USD | Capex + M&AM USD | AssetsM USD | EquityM USD | ROE (annualized) | Net debtM USD | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | FY 2025 (12M) | OK | 142.4 y/y 15.4% | 55.4 y/y 16.8% | 4.3 y/y 6.8% | 59.7 y/y 16.0% | 38.2 y/y 17.9% | -0.8 | — | 746.6 y/y 7.5% | 465.6 y/y 31.0% | 19.3% | 9288.5 | — |
| 2025-09-30 | Q3 2025 (3M) | PARTIAL | 114.6 y/y 52.7% | 40.4 y/y 138.3% | 4.4 y/y 0.0% | 44.8 y/y 110.0% | 24.3 y/y 356.3% | 7.7 | — | 720.0 y/y 25.8% | 430.2 y/y 33.7% | 7.7% | 17214.0 | — |
| 2025-06-30 | Q2 2025 (3M) | OK | 89.9 y/y -4.2% | 24.4 y/y -15.1% | 4.5 y/y 19.8% | 28.9 y/y -11.1% | 10.1 y/y -37.2% | 32.8 | -33.9 | 706.1 y/y 31.0% | 408.2 y/y 30.0% | 10.4% | 7296.4 | — |
| 2025-03-31 | Q1 2025 (3M) | PARTIAL | 96.1 y/y 45.2% | 31.0 y/y 70.0% | 3.6 y/y 0.0% | 34.6 y/y 58.4% | 13.9 y/y 28.0% | 5.9 | — | 696.1 y/y — | 369.3 y/y — | 15.4% | 18997.0 | — |
| 2024-12-31 | FY 2024 (12M) | OK | 123.4 y/y — | 47.5 y/y — | 4.1 y/y — | 51.5 y/y — | 32.4 y/y — | -5.6 | -18.9 | 694.8 y/y 45.2% | 355.3 y/y 48.0% | 19.1% | 10167.4 | — |
| 2024-09-30 | Q3 2024 (3M) | OK | 75.0 y/y -8.5% | 17.0 y/y -53.1% | 4.4 y/y 1404.3% | 21.3 y/y -41.5% | 5.3 y/y -80.4% | -11.7 | -18.9 | 572.1 y/y — | 321.7 y/y — | 2.2% | 10097.0 | — |
| 2024-06-30 | Q2 2024 (3M) | OK | 93.9 y/y 73.1% | 28.7 y/y 186.5% | 3.8 y/y 19.4% | 32.5 y/y 146.6% | 16.0 y/y 253.1% | 66.2 | -9.4 | 539.1 y/y — | 313.9 y/y — | — | 8209.8 | — |
| 2024-03-31 | Q1 2024 (3M) | PARTIAL | 66.2 y/y — | 18.2 y/y — | 3.6 y/y — | 21.8 y/y — | 10.9 y/y — | 32.8 | -9.4 | — y/y — | — y/y — | — | 10006.0 | — |
| 2023-12-31 | FY 2023 (12M) | OK | — y/y — | — y/y — | — y/y — | — y/y — | — y/y — | — | — | 478.5 y/y — | 240.1 y/y — | — | 13478.1 | — |
| 2023-09-30 | Q3 2023 (3M) | PARTIAL | 82.0 y/y — | 36.2 y/y — | 0.3 y/y — | 36.5 y/y — | 27.1 y/y — | 22.6 | -3.6 | — y/y — | — y/y — | — | 9058.0 | — |
| 2023-06-30 | Q2 2023 (3M) | PARTIAL | 54.2 y/y — | 10.0 y/y — | 3.2 y/y — | 13.2 y/y — | 4.5 y/y — | 28.9 | -6.0 | — y/y — | — y/y — | — | 9458.0 | — |
2025-09-30 Q3: Missing metrics: investing_cash_flow.2025-09-30 9M: Missing metrics: investing_cash_flow.2025-03-31 Q1: Missing metrics: investing_cash_flow.2024-03-31 Q1: Assets and/or equity missing while cash/debt are present — often a unit-scale mismatch after extraction.2023-09-30 9M: Missing metrics: investing_cash_flow.2025-09-30 Q3: Status PARTIAL (incomplete extraction or legacy OCR warnings).2025-09-30 9M: Status PARTIAL (incomplete extraction or legacy OCR warnings).2025-03-31 Q1: Status PARTIAL (incomplete extraction or legacy OCR warnings).2024-03-31 Q1: Status PARTIAL (incomplete extraction or legacy OCR warnings).2023-09-30 Q3: Status PARTIAL (incomplete extraction or legacy OCR warnings).2023-09-30 9M: Status PARTIAL (incomplete extraction or legacy OCR warnings).2023-06-30 Q2: Status PARTIAL (incomplete extraction or legacy OCR warnings).Quarterly values ($ mln)
Year-over-year change
Net debt / cash ($ mln)
Value the company creates per year, as a % of market cap
Value created per year: +173.7%
| 1. EBITDA growth (latest quarter YoY, annualised) [EBITDA latest qtr − EBITDA year-ago qtr] × annualisation X (2025-12-31 vs 2024-12-31) = (60 − 51) × 2.81 | 24 |
| 2. Current EV/EBITDA (LTM) (Market cap + Net debt) ÷ EBITDA (LTM) = (754 + 9 288) ÷ 168 | 30.0x — capped at 30x |
| 3. Target multiple (Current EV/EBITDA + 6.5) ÷ 2 = (30.0 + 6.5) ÷ 2 | 18.2x |
| 4. Cash flow (balance method, LTM) Net-debt reduction + dividends + buybacks − equity issuance = 879 + 0 + 0 − 0 | 879 |
| 5. Value created per year (EBITDA growth × Target multiple + Cash flow) ÷ Market cap = (24 × 18.2 + 879) ÷ 754 | +173.7% |
Amounts in millions of the reporting currency. EBITDA growth is the latest quarter vs the same quarter a year ago, annualised.
Caveats:
No dividend rows found for this issuer.
Reporting forms detected in loaded periods: ✓ ✓ ✓ (Balance sheet / Profit or loss (P&L) / Cash flows)